Xeris Biopharma Holdings Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 08/07/2026 | 14.53 M | $115.04 M | 12.20% | 8.40% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 7.80 M | $61.81 M | 0.20% | 4.52% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 7.34 M | $58.13 M | 5.15% | 4.25% |
| STATE STREET CORP | 08/07/2026 | 4.82 M | $38.19 M | 3.51% | 2.79% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 4.72 M | $37.37 M | 9.96% | 2.73% |
| NUVEEN, LLC | 08/11/2026 | 4.39 M | $34.73 M | 50.35% | 2.54% |
| ROSALIND ADVISORS, INC. | 08/14/2026 | 2.91 M | $23.04 M | -9.99% | 1.68% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2026 | 2.89 M | $22.92 M | -29.67% | 1.67% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 2.63 M | $20.80 M | -1.48% | 1.52% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 2.37 M | $18.73 M | 8.92% | 1.37% |
| MORGAN STANLEY | 08/13/2026 | 2.34 M | $18.51 M | -9.16% | 1.35% |
| LEGAL & GENERAL GROUP PLC | 08/14/2026 | 2.01 M | $15.94 M | 5.48% | 1.16% |
| ARMISTICE CAPITAL, LLC | 08/14/2026 | 1.96 M | $15.51 M | 2.56% | 1.13% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 1.89 M | $14.93 M | -2.01% | 1.09% |
| PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2026 | 1.81 M | $14.32 M | 5.02% | 1.05% |
| ALGERT GLOBAL LLC | 08/13/2026 | 1.74 M | $13.80 M | 50.65% | 1.01% |
| NORTHERN TRUST CORP | 08/13/2026 | 1.60 M | $12.65 M | 10.60% | 0.92% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 1.59 M | $12.63 M | -1.21% | 0.92% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 1.54 M | $12.20 M | 10.51% | 0.89% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 1.49 M | $11.82 M | 9.76% | 0.86% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 1.49 M | $11.82 M | 100.00% | 0.86% |
| FEDERATED HERMES, INC. | 08/12/2026 | 1.43 M | $11.36 M | 67.41% | 0.83% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 1.40 M | $11.06 M | 59.77% | 0.81% |
| UBS GROUP AG | 08/13/2026 | 1.30 M | $10.30 M | -20.98% | 0.75% |
| ISHARA INVESTMENTS LP | 08/14/2026 | 1.23 M | $9.74 M | 20.00% | 0.71% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 1.22 M | $9.70 M | 7.98% | 0.71% |
| KENNEDY CAPITAL MANAGEMENT LLC | 08/14/2026 | 1.21 M | $9.58 M | -2.55% | 0.70% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 1.07 M | $8.50 M | 100.00% | 0.62% |
| KNOTT DAVID M JR | 08/12/2026 | 1.06 M | $8.40 M | 0.00% | 0.61% |
| JPMORGAN CHASE & CO | 08/12/2026 | 1.06 M | $8.19 M | 72.75% | 0.61% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 08/13/2026 | 972.88 K | $7.71 M | 627.33% | 0.56% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 08/14/2026 | 898.75 K | $7.12 M | -2.51% | 0.52% |
| NORGES BANK | 08/12/2026 | 797.20 K | $6.31 M | 100.00% | 0.46% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 08/06/2026 | 715.61 K | $5.67 M | -4.30% | 0.41% |
| UBS ASSET MANAGEMENT AMERICAS INC | 08/13/2026 | 687.63 K | $5.45 M | 2.93% | 0.40% |
| VOYA INVESTMENT MANAGEMENT LLC | 08/12/2026 | 685.57 K | $5.43 M | 9.64% | 0.40% |
| CITADEL ADVISORS LLC | 09/02/2026 | 664.56 K | $5.26 M | -2.50% | 0.38% |
| FMR LLC | 08/13/2026 | 644.06 K | $5.10 M | 25.53% | 0.37% |
| WALLEYE CAPITAL LLC | 08/03/2026 | 611.30 K | $4.84 M | 100.00% | 0.35% |
| DEUTSCHE BANK AG\ | 08/07/2026 | 529.44 K | $4.19 M | -15.02% | 0.31% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 488.44 K | $3.87 M | 14.58% | 0.28% |
| FIRST TRUST ADVISORS LP | 08/11/2026 | 484.98 K | $3.84 M | 100.00% | 0.28% |
| IHT WEALTH MANAGEMENT, LLC | 08/14/2026 | 481.87 K | $3.82 M | 28.00% | 0.28% |
| PERCEPTIVE ADVISORS LLC | 08/14/2026 | 467.01 K | $3.70 M | 100.00% | 0.27% |
| ROYCE & ASSOCIATES LP | 08/14/2026 | 461.15 K | $3.65 M | 80.08% | 0.27% |
| MAN GROUP PLC | 08/14/2026 | 455.38 K | $3.61 M | 64.74% | 0.26% |
| CAPTION MANAGEMENT, LLC | 08/14/2026 | 443.50 K | $3.51 M | 0.00% | 0.26% |
| RUSSELL INVESTMENTS GROUP, LTD. | 08/06/2026 | 440.73 K | $3.49 M | 14.72% | 0.26% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 430.49 K | $3.41 M | 63.82% | 0.25% |
| STATE OF WISCONSIN INVESTMENT BOARD | 08/14/2026 | 427.51 K | $3.39 M | 38.56% | 0.25% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Xeris Biopharma Holdings Inc institutional Ownership - FAQ's
During the previous two years, 298 institutional investors and hedge funds held shares of Xeris Biopharma Holdings Inc. The most heavily invested institutionals were:
BlackRock, Inc.: 14.53 M
D. E. Shaw & Co., Inc.: 7.8 M
VANGUARD CAPITAL MANAGEMENT LLC: 7.34 M
STATE STREET CORP: 4.82 M
GEODE CAPITAL MANAGEMENT, LLC: 4.72 M
Nuveen, LLC: 4.39 M
63.50% of Xeris Biopharma Holdings Inc stock is owned by institutional investors.
Institutional investors have bought a total of 135.65 M shares in the last 24 months. This purchase volume represents approximately $759.66 M in transactions.